WallStSmart

Henry Schein Inc (HSIC)vsQuipt Home Medical Corp (QIPT)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Henry Schein Inc generates 5083% more annual revenue ($13.73B vs $264.97M). HSIC leads profitability with a 3.1% profit margin vs -0.0%. HSIC earns a higher WallStSmart Score of 53/100 (C-).

HSIC

Buy

53

out of 100

Grade: C-

Growth: 5.3Profit: 5.5Value: 6.7Quality: 5.0
Piotroski: 2/9Altman Z: 2.37

QIPT

Hold

40

out of 100

Grade: D

Growth: 5.3Profit: 2.5Value: 5.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HSICUndervalued (+48.0%)

Margin of Safety

+48.0%

Fair Value

$157.15

Current Price

$84.96

$72.19 discount

UndervaluedFair: $157.15Overvalued
QIPTUndervalued (+8.7%)

Margin of Safety

+8.7%

Fair Value

$3.90

Current Price

$3.65

$0.25 discount

UndervaluedFair: $3.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HSIC2 strengths · Avg: 8.0/10
Price/BookValuation
3.0x8/10

Reasonable price relative to book value

EPS GrowthGrowth
26.2%8/10

Earnings expanding 26.2% YoY

QIPT1 strengths · Avg: 8.0/10
Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Areas to Watch

HSIC4 concerns · Avg: 3.5/10
PEG RatioValuation
1.734/10

Expensive relative to growth rate

Revenue GrowthGrowth
4.0%4/10

4.0% revenue growth

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

Debt/EquityHealth
1.233/10

Elevated debt levels

QIPT4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.3%4/10

0.3% revenue growth

Market CapQuality
$162.30M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HSIC

The strongest argument for HSIC centers on Price/Book, EPS Growth.

Bull Case : QIPT

The strongest argument for QIPT centers on Price/Book.

Bear Case : HSIC

The primary concerns for HSIC are PEG Ratio, Revenue Growth, Profit Margin. Thin 3.1% margins leave little buffer for downturns.

Bear Case : QIPT

The primary concerns for QIPT are Revenue Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

HSIC profiles as a value stock while QIPT is a turnaround play — different risk/reward profiles.

HSIC carries more volatility with a beta of 0.86 — expect wider price swings.

HSIC is growing revenue faster at 4.0% — sustainability is the question.

HSIC generates stronger free cash flow (131M), providing more financial flexibility.

Bottom Line

HSIC scores higher overall (53/100 vs 40/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Henry Schein Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.

Visit Website →

Quipt Home Medical Corp

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.

Want to dig deeper into these stocks?